Roos J. Blankespoor

Maastricht University Medical Centre

Papers

1

Total Citations

76

H-Index

1

About

Dr. Roos J. Blankespoor is a pioneering clinical researcher whose work bridges the critical gap between neuroimmunology and developmental psychiatry. Her most influential study, "Late onset autism and anti-NMDA-receptor encephalitis" (2011), with 76 citations, fundamentally challenged conventional views of autism spectrum disorders by demonstrating that some cases of regressive autism may be triggered by an autoimmune encephalitis. This landmark paper established a new diagnostic paradigm, showing that anti-NMDA-receptor antibodies can cause a reversible, treatable form of autism-like symptoms in children and adolescents. Dr. Blankespoor's research has been instrumental in alerting clinicians to consider autoimmune etiologies in patients presenting with late-onset or regressive autism, leading to earlier diagnosis and potentially life-changing immunotherapy interventions. Her work has significantly advanced the understanding of how neuroinflammatory processes can mimic or exacerbate neurodevelopmental conditions, opening new avenues for targeted treatments. Through her meticulous case studies and clinical insights, Dr. Blankespoor has become a leading voice in the emerging field of autoimmune neuropsychiatry, inspiring a generation of researchers to explore the immune system's role in complex developmental disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
76
Total Citations
76
Avg Citations/Paper
🏆 Most Cited Paper
Late onset autism and anti-NMDA-receptor encephalitis
76 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Maastricht University Medical Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago